GALERA THERAPEUTICS INC (GRTX)

US36338D1081 - Common Stock

0.1861  -0.02 (-10.31%)

After market: 0.1879 +0 (+0.97%)

News Image
6 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!

News Image
11 days ago - Chartmill

Top movers in Wednesday's after hours session

Get insights into the top gainers and losers of Wednesday's after-hours session.

News Image
11 days ago - Chartmill

Top movers in Wednesday's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

News Image
11 days ago - Chartmill

Which stocks are experiencing notable movement on Wednesday?

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

News Image
11 days ago - Chartmill

Top movers in Wednesday's pre-market session

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image
11 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!

News Image
a month ago - InvestorPlace

GRTX Stock Earnings: Galera Therapeutics Beats EPS for Q4 2023

GRTX stock results show that Galera Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

News Image
a month ago - Galera Therapeutics

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Company continues to evaluate strategic options to maximize shareholder value

News Image
a month ago - Galera Therapeutics

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Company continues to evaluate strategic options to maximize shareholder value...

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!

News Image
6 months ago - Galera Therapeutics

Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

FDA confirms need for new trial for avasopasem; GRECO trials with rucosopasem to be discontinued Company evaluating potential strategic options to...

News Image
6 months ago - Seeking Alpha

Galera stock plunges on risks to business continuity

Galera Therapeutics (GRTX) plunges after announcing that the company will be forced to discontinue operations if it fails to find strategic alternatives. Read more here.

News Image
6 months ago - Galera Therapeutics

Galera Announces Receipt of Type A Meeting Minutes and Strategic Update

FDA confirms need for new trial for avasopasem for severe oral mucositis (SOM) GRECO-2 trial did not pass futility analysis; Company will discontinue both...